Untreated nBCC
Showing 1 - 25 of 2,547
Basal Cell Carcinoma, Basal Cell Nevus Syndrome Trial in Australia (ASN-002)
Recruiting
- Basal Cell Carcinoma
- Basal Cell Nevus Syndrome
- ASN-002
-
Brisbane, Queensland, Australia
- +5 more
Feb 10, 2022
Uveal Melanoma Trial in Pittsburgh (Tebentafusp)
Not yet recruiting
- Uveal Melanoma
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Oct 5, 2023
PARP Inhibitor for Esophageal Squamous Cell Carcinoma Trial (Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only
Not yet recruiting
- PARP Inhibitor for Esophageal Squamous Cell Carcinoma
- Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only non-small cell lung cancer arm) ,or Fluzoparib combined with capecitabine (only rectal cancer arm))
- (no location specified)
Sep 24, 2023
Diffuse Large B Cell Lymphoma (DLBCL) Trial in Toronto (glofitamab)
Not yet recruiting
- Diffuse Large B Cell Lymphoma (DLBCL)
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Sep 18, 2023
Follicular Lymphoma, Tumor Trial in Houston (Obinutuzumab, CC-99282)
Not yet recruiting
- Follicular Lymphoma
- Tumor
-
Houston, TexasM D Anderson Cancer Center
Oct 30, 2023
Transverse Maxillary Deficiency Trial in Cairo (Hybrid Hyrax)
Active, not recruiting
- Transverse Maxillary Deficiency
- Hybrid Hyrax
-
Cairo, Giza, Egyptfaculty of dentistry, Cairo university
Nov 8, 2023
Obinutuzumab-based Therapy for Previously Untreated FL
Recruiting
- Follicular Lymphoma
- Obinutuzumab
- +6 more
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University School of Medicin
Jun 3, 2023
Non Small Cell Lung Cancer Metastatic, Brain Metastases, Adult, KRAS G12C Trial (JDQ443)
Not yet recruiting
- Non Small Cell Lung Cancer Metastatic
- +2 more
- (no location specified)
Aug 11, 2023
Transverse Maxillary Deficiency Trial in Cairo (Hybrid hyrax)
Active, not recruiting
- Transverse Maxillary Deficiency
- Hybrid hyrax
-
Cairo, Giza, EgyptFaculty of Dentistry, Cairo university
Aug 30, 2023
Advanced Melanoma Trial in Worldwide (IMC-F106C, Nivolumab, Nivolumab + Relatlimab)
Not yet recruiting
- Advanced Melanoma
- IMC-F106C
- +2 more
-
La Jolla, California
- +61 more
Oct 31, 2023
Parkinson Disease Trial (CVN424 150 mg, Placebo)
Not yet recruiting
- Parkinson Disease
- CVN424 150 mg
- Placebo
- (no location specified)
Aug 25, 2023
Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- (no location specified)
Jul 10, 2023
Follicular Lymphoma Stage II, Follicular Lymphoma Stage III, Follicular Lymphoma Stage IV Trial in Australia (BMS-986369,
Not yet recruiting
- Follicular Lymphoma Stage II
- +2 more
- BMS-986369
- +2 more
-
Ballarat, Victoria, Australia
- +4 more
Mar 15, 2023
Follicular Lymphoma Trial in Italy (Radiotherapy, Radiotherapy plus Obinotuzumab)
Not yet recruiting
- Follicular Lymphoma
- Radiotherapy
- Radiotherapy plus Obinotuzumab
-
Alessandria, Italy
- +47 more
Jun 26, 2023
Hemodynamics in People With Untreated Preeclampsia Using
Not yet recruiting
- Preeclampsia
- Transthoracic Echocardiography
-
Boston, MassachusettsBrigham and Women's Hospital
Oct 23, 2023
Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)
Not yet recruiting
- Acute Myeloid Leukemia
- Mitoxantrone hydrochloride liposome injection
- +3 more
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jul 1, 2023
Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)
Not yet recruiting
- Acute Myeloid Leukemia
- Mitoxantrone hydrochloride liposome injection
- +3 more
- (no location specified)
May 29, 2023
Postmenopausal Symptoms, Hot Flashes Trial in Kalmar, Linköping (Strength training, High-intensity aerobic training)
Not yet recruiting
- Postmenopausal Symptoms
- Hot Flashes
- Strength training
- High-intensity aerobic training
-
Kalmar, Sweden
- +1 more
Sep 8, 2023
Hypertension, Behavior and Behavior Mechanisms Trial (Written persuasive leaflet, Standard referral leaflet)
Not yet recruiting
- Hypertension
- Behavior and Behavior Mechanisms
- Written persuasive leaflet
- Standard referral leaflet
- (no location specified)
Jul 20, 2023
Neovascular Age-Related Macular Degeneration Trial in China (Brolucizumab 6mg, Aflibercept 2 mg)
Recruiting
- Neovascular Age-Related Macular Degeneration
- Brolucizumab 6mg
- Aflibercept 2 mg
-
Guangzhou, Guangdong, China
- +30 more
Jan 20, 2023
Pancreatic Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic Trial in Scottsdale (Botensilimab, Balstilimab, Chloroquine
Not yet recruiting
- Pancreatic Cancer Metastatic
- Pancreatic Adenocarcinoma Metastatic
- Botensilimab
- +3 more
-
Scottsdale, ArizonaClinical Trials Nurse Navigator
Oct 3, 2023
Waldenstrom's Macroglobulinemia Trial in Boston (Ibrutinib)
Completed
- Waldenstrom's Macroglobulinemia
-
Boston, Massachusetts
- +1 more
Dec 5, 2022
Schizophrenia, First Episode Psychosis Trial in Glen Oaks, Queens (search engine advertisement campaign)
Active, not recruiting
- Schizophrenia
- First Episode Psychosis
- search engine advertisement campaign
-
Glen Oaks, New York
- +1 more
Sep 27, 2022
Non Hodgkin Lymphoma Trial in United Kingdom (R-CHOP + acalabrutinib)
Active, not recruiting
- Non Hodgkin Lymphoma
- R-CHOP + acalabrutinib
-
Southampton, Hampshire, United Kingdom
- +6 more
Oct 26, 2022
Pompe Disease Trial in New York, Fairfax (biological, drug, other)
Not yet recruiting
- Pompe Disease
- Cipaglucosidase alfa
- +3 more
-
New York, New York
- +1 more
Nov 2, 2023